Evidence map›Paper›PMID 42877129›Full record

ArticleFrontiers in plant science2026

LMF-YOLO: a multi-scale inception model for edge-based strawberry disease detection.

Yuzhen Niu, Ping Lin

Abstract read
In one paragraph

Article in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yuzhen NiuCollege of Chemical Engineering and Environment, Weifang University of Science and Technology, Weifang, China.
Ping LinCollege of Chemical Engineering and Environment, Weifang University of Science and Technology, Weifang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid and precise identification of strawberry diseases is paramount for securing crop yield and quality. To address challenges arising from significant scale variations, diminutive early-stage lesions, and high inter-class visual similarity, this study proposes a parameter-efficient multi-scale feature fusion network derived from YOLO26, termed LMF-YOLO. The architecture incorporates three strategic enhancements: First, leveraging the end-to-end NMS-free framework of YOLO26, a Triple Feature Encoder (TFE) is developed to aggregate multi-scale features in a one-shot manner, preserving critical high resolution spatial details. Second, a lightweight Multi-scale Initialization Module (MSInit), utilizing separable dilated convolutions, captures contextual information across diverse receptive fields, enhancing the model's discriminative power against visually similar diseases. Third, a P2 micro-detection head is added to provide explicit supervision for extremely early tiny lesions. Evaluations on a custom strawberry disease dataset (7 categories, 6,246 annotations) demonstrate that the proposed model LMF-YOLO (YOLO26n + LMF neck + P2 head) achieves an mAP50 of 82.0%, marking a 1.9 percentage point increase over the baseline YOLO26n. Notably, the model yields an 11.5% improvement in AP_small for early lesions. Following TensorRT acceleration on the Jetson Nano, the model achieves an inference latency of 33.6 ms (~30 FPS), meeting the real-time constraints for mobile-based recognition. Ablation and comparative studies confirm that LMF-YOLO outperforms mainstream YOLO variants in balancing computational efficiency with detection sensitivity, providing a robust technical solution for mobile-intelligent strawberry disease diagnostics.

Indexed as

lightweight networkmulti-scale feature fusionphotograph-based recognitionstrawberry disease detectionYOLO26

Identifiers

PMID42877129
PMCPMC13662136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.